Watson launches generic of ViroPharma's antibiotic
(Reuters) - Generic drugmaker Watson Pharmaceuticals Inc said U.S. health regulators approved its copycat version of ViroPharma Inc's antibiotic Vancocin.
Separately, ViroPharma said the U.S. Food and Drug Administration declined its citizen petition, which was filed to prevent Watson from launching the generic version.
Shares of ViroPharma were trading down 18 percent at $23.40 in premarket.
Watson said it has started shipping the drug, which recorded sales of $332 million for the 12 months ended February 29, 2012.
ViroPharma shares closed at $28.61 on Monday on the Nasdaq.
(Reporting by Anand Basu in Bangalore; Editing by Sriraj Kalluvila)
- Tweet this
- Share this
- Digg this
- Sweden gets two new sightings, as hunt for undersea intruder goes on
- UPDATE 4-NY says Ocwen backdated foreclosure letters, company shares slide
- U.S. to funnel travelers from Ebola-hit region through 5 airports
- New Total boss must overhaul exploration strategy, pursue cost cuts
- Indiana police charge suspect who may have killed for decades
India stepped up its efforts on Tuesday to prevent an outbreak of the deadly Ebola virus, conducting mock drills at its airports and installing surveillance systems. Full Article